About this ETF
This investment vehicle aims to deliver sustained appreciation of capital over an extended period.
Description from the fund data provider · profile as of Oct 10, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -3.08% | -6.45% | +11.27% | +13.34% | — | — | — | — | +15.58% |
| Total return | -3.08% | -6.45% | +11.27% | +13.34% | — | — | — | — | +15.58% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 09, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.49% | Annual cost of a $10,000 investment | $49.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 10, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 313 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | KRYSTAL BIOTECH INC COMMON STOCK USD.00001 | KRYS | 0.95% | 1.50K | $490.9K |
| 2 | CECO ENVIRONMENTAL CORP COMMON STOCK USD.01 | CECO | 0.93% | 7.29K | $477.9K |
| 3 | 10X GENOMICS INC CLASS A COMMON STOCK USD.00001 | TXG | 0.88% | 5.84K | $451.3K |
| 4 | SENSIENT TECHNOLOGIES CORP COMMON STOCK USD.1 | SXT | 0.84% | 3.27K | $431.7K |
| 5 | HEXCEL CORP COMMON STOCK USD.01 | HXL | 0.83% | 5.04K | $429.0K |
| 6 | PLEXUS CORP COMMON STOCK USD.01 | PLXS | 0.83% | 1.64K | $427.4K |
| 7 | EXPRO LTD COMMON STOCK USD.0001 | XPRO | 0.79% | 25.10K | $406.9K |
| 8 | AGILYSYS INC COMMON STOCK USD.3 | AGYS | 0.77% | 3.86K | $396.2K |
| 9 | RADNET INC COMMON STOCK USD.0001 | RDNT | 0.75% | 5.66K | $386.1K |
| 10 | IMPINJ INC COMMON STOCK USD.001 | PI | 0.74% | 2.07K | $380.1K |
| 11 | PROTAGONIST THERAPEUTICS INC COMMON STOCK… | PTGX | 0.74% | 2.71K | $378.6K |
| 12 | ENCOMPASS HEALTH CORP COMMON STOCK USD.01 | EHC | 0.73% | 3.08K | $377.8K |
| 13 | NOVANTA INC COMMON STOCK | 0VAG.L | 0.71% | 2.69K | $366.5K |
| 14 | ONTO INNOVATION INC COMMON STOCK | ONTO | 0.71% | 1.25K | $366.1K |
| 15 | ESCO TECHNOLOGIES INC COMMON STOCK USD.01 | ESE | 0.71% | 1.44K | $365.3K |
| 16 | LIFE TIME GROUP HOLDINGS INC COMMON STOCK USD.01 | LTH | 0.71% | 9.03K | $363.9K |
| 17 | RALLIANT CORP COMMON STOCK USD.01 | RAL | 0.70% | 5.03K | $361.5K |
| 18 | MAGNITE INC COMMON STOCK USD.00001 | MGNI | 0.70% | 14.13K | $359.7K |
| 19 | OMADA HEALTH INC COMMON STOCK USD.001 | OMDA | 0.69% | 16.95K | $353.0K |
| 20 | TWIST BIOSCIENCE CORP COMMON STOCK USD.00001 | TWST | 0.68% | 2.30K | $350.0K |
| 21 | LITTELFUSE INC COMMON STOCK USD.01 | LFUS | 0.66% | 802 | $341.1K |
| 22 | TRANSALTA CORP COMMON STOCK | TA.TO | 0.66% | 26.31K | $339.4K |
| 23 | MATERION CORP COMMON STOCK | MTRN | 0.65% | 1.22K | $336.7K |
| 24 | ARGAN INC COMMON STOCK USD.15 | AGX | 0.64% | 821 | $327.3K |
| 25 | HEALTHEQUITY INC COMMON STOCK USD.0001 | HQY | 0.63% | 3.46K | $322.0K |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | — | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | — | Last payment | — |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
No distributions in our database for this fund; it may not pay them, or history has not loaded yet.
Risk Statistics
| Volatility 1Y / 3Y | 21.36% / — | Sharpe 1Y / 3Y | 0.687 / — |
| Max drawdown 1Y / 3Y | -13.29% / — | Sortino 1Y | 1.02 |
| Beta vs S&P 500 (3Y) | 1.14 | Correlation vs S&P 500 (1Y) | 0.851 |
| Downside deviation 1Y | 14.36% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 10, 2026. Formulas →
Liquidity
| Volume today | 1.69K | Average volume | 9.72K |
| AUM | $51.4M | Premium/Discount | +1.27% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | -$264.0K | -0.51% | $51.7M → $51.4M |
| 1 Month | $766.3K | +1.49% | $51.5M → $51.4M |
| 1 Week | $532.2K | +1.04% | $51.3M → $51.4M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for ACSG
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
ACSG